SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (1182)11/18/1997 8:09:00 PM
From: Dennis Vail  Read Replies (2) of 2205
 
David,

If you read carefully you'll notice that the release mentions that today's presentation is the first time detailed data from the supplemental trial has been disclosed. My guess would be that they are including a press release on it to keep the SEC off their back, the same way companies generally release a synopsis of their earnings report by wire shortly BEFORE they hold the teleconference. Keeps the playing field marginally level. And I'd imagine ATIS and it's shareholders consider this information somewhat more important than its largely irrelevant at this point quarterly earnings reports.

" LA JOLLA, Calif., Nov. 18 /PRNewswire/ -- Gail K. Naughton, Ph.D., President and Chief Operating Officer of Advanced Tissue Sciences, Inc., today presented data from the pivotal and supplemental clinical trials of Dermagraft in the treatment of diabetic foot ulcers at the Biomaterials of the Future Conference in San Francisco. This marks the first time detailed data from the supplemental clinical trial and pooled results from both trials have been disclosed. The combined data shows that Dermagraft (within a specified therapeutic range based on metabolic activity) is significantly more effective than the control treatment, achieving complete healing of these severe ulcers in 51% of the patients in twelve weeks."

Regards,
Dennis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News